# Acceptance-risk assessment

## Bottom line

The paper is **borderline, leaning weak reject**, but has a credible acceptance path. This is a reasoned assessment, not a prediction of the program committee's decision.

The strongest positioning is: **a prospectively governed agent-safety methodology and negative-results paper**. Do not present RAER as validated, superior, production-ready, or supported by held-out effectiveness evidence.

## Reasons reviewers may accept it

- Timely problem: AI agents acting on stale authorization, policy, identity, scope, or operational evidence.
- Strong integrity: hypotheses, selection rules, and gates were frozen prospectively and not relaxed after failure.
- Reproducible design: benchmark provenance, adjudication, code, tests, raw outcomes, bootstrap intervals, ablations, locks, and closure records are preserved.
- Valuable negative result: lower harm and checking cost did not justify ignoring insufficient safe completion.
- Clear safety lesson: the failed gate protected the sealed held-out partition from an underpowered or overinterpreted evaluation.
- Strong topical fit with trustworthy AI, responsible AI, agent safety, runtime governance, and tool-use safety.

## Reasons reviewers may reject it

- The primary hypothesis failed: 92.6% safe completion versus the required 95%.
- No confirmatory held-out evaluation was run; effectiveness remains unvalidated.
- The 96-case benchmark is constructed rather than a real deployment or external dataset.
- Only 27 all-valid design cases determine safe completion, producing coarse increments and wide uncertainty.
- Novelty is deliberately narrow; reviewers may view RAER as an integration of abstention, evidence acquisition, and runtime verification.
- Model-based reviewers and rubric-derived measures provide AI-AI consistency, not independent human or domain-expert reliability.
- Several closest references are recent preprints rather than mature peer-reviewed foundations.

## Ethical improvements before submission

Permissible improvements are clearer framing, stronger exposition, exact source verification, clearer limitations, and improved reproducibility navigation. Impermissible improvements include changing thresholds, selecting different metrics after seeing results, opening held-out labels, calling design results confirmatory, or claiming broad novelty/superiority.

## Reviewer-facing message

The study's contribution is not that RAER succeeded. The contribution is a reproducible method for prospective evidence-revalidation evaluation and a preserved failure showing that favorable harm-cost summaries can coexist with inadequate cross-domain completion.

